Daisuke Muraoka (Yosuke Dotsu)

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Daisuke Muraoka, Meng Ling Moi, Osamu Muto, Takaaki Nakatsukasa, Situo Deng, Chieko Takashima, Rui Yamaguchi, Shin-Ichi Sawada, Haruka Hayakawa, Thi Thanh Ngan Nguyen, Yasunari Haseda, Takatoshi Soga, Hirokazu Matsushita, Hiroaki Ikeda, Kazunari Akiyoshi, Naozumi Harada
Low-frequency CD8 + T cells induced by SIGN-R1 + macrophage-targeted vaccine confer SARS-CoV-2 clearance in mice. NPJ vaccines 9 (1) (2024)
Satomi Okada, Daisuke Muraoka, Kiyoshi Yasui, Isao Tawara, Ayumi Kawamura, Sachiko Okamoto, Junichi Mineno, Naohiro Seo, Hiroshi Shiku, Susumu Eguchi, Hiroaki Ikeda
T cell receptor gene-modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft-versus-host disease. Cancer science (2023)
Daisuke Muraoka, Daisuk Muraoka, Naohisa Ogo, Yudai Sonoda, Kiyoshi Yasui, Hiroyuki Yamaguchi, Hideo Yagita, Hiroshi Mukae, Akira Asai, Hiroaki Ikeda
Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumors. Journal for immunotherapy of cancer 10 (2) (2022)

Daisuke Muraoka.css-eqlu8i{font-size:small;padding-left:4px;} (Yosuke Dotsu)